Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on offer for subscription

14 Aug 2020 14:36

RNS Number : 2272W
Amati AIM VCT PLC
14 August 2020
 

14 August 2020

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Update on offer for subscription

The Board of Amati AIM VCT plc (the "Company") announced on 31 October 2019 that the Company had published a prospectus in connection with proposals to raise up to £25,000,000 (with an over-allotment facility to raise up to a further £20,000,000), by way of an offer for subscription (the "Offer") of new ordinary shares (the "New Shares").

The Company announced on 29 April 2020 that £25,000,000 had been raised under the Offer and that the Board had decided not to utilise the over-allotment facility at that time. However, the Company has continued to identify and make new investments, with around £11.4 million new qualifying investments being made since the start of the Company's financial year on 1 February 2020.

Having considered the current rate of investment activity, the Board is pleased to announce that the Offer has now re-opened and the Company is seeking to raise up to £20,000,000 available under the over-allotment facility. The next allotment of New Shares under the Offer is expected to be on or around 14 September 2020 and thereafter allotments will be made at the discretion of the Board. The Offer will close at 12 noon on 16 October 2020 (unless the Offer is fully subscribed before this date and/or the Board closes the Offer earlier, which it may do in its sole discretion).

The Prospectus is available at www.amatiglobal.com and https://data.fca.org.uk/#/nsm/nationalstoragemechanism and, until 30 October 2020, copies are available for collection, free of charge, from the offices of Amati Global Investors and the offices of Dickson Minto W.S. on any Business Day. Copies can also be requested by contacting Amati Global Investors on +44 (0)131 503 9115 or by email at info@amatiglobal.com.

Subscriptions can be made online at www.amatioffer.com or by completing the subscription form contained in the Prospectus.

For further information, please contact Samantha Dalby on +44 (0)131 503 9115 or email: info@amatiglobal.com

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations ((EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPEADPLFDLEEFA
Date   Source Headline
2nd May 20253:29 pmRNSNet Asset Value(s)
1st May 20255:31 pmRNSChange of Manager, Change of Name and Board Change
1st May 202510:42 amRNSTotal Voting Rights
25th Apr 20255:00 pmRNSNet Asset Value(s)
23rd Apr 202512:16 pmRNSTransaction in Own Shares
23rd Apr 20259:33 amRNSNet Asset Value(s)
16th Apr 202512:32 pmRNSTransaction in Own Shares
16th Apr 20257:02 amRNSDividend Declaration
16th Apr 20257:01 amRNSAnnual Financial Report
16th Apr 20257:00 amRNSUpdate on Change of Investment Manager
9th Apr 20252:39 pmRNSTransaction in Own Shares
7th Apr 202510:39 amRNSTransaction in Own Shares
4th Apr 20254:46 pmRNSNet Asset Value(s)
4th Apr 20252:32 pmRNSTransaction in Own Shares
3rd Apr 20254:29 pmRNSTransaction in Own Shares
1st Apr 20254:34 pmRNSNet Asset Value(s)
1st Apr 202512:38 pmRNSTotal Voting Rights
31st Mar 20255:00 pmRNSTransaction in Own Shares
26th Mar 20259:57 amRNSTransaction in Own Shares
25th Mar 20258:54 amRNSTransaction in Own Shares
21st Mar 20254:05 pmRNSNet Asset Value(s)
14th Mar 20254:06 pmRNSNet Asset Value(s)
10th Mar 202511:35 amRNSCompliance with Market Abuse Regulation
7th Mar 20254:12 pmRNSNet Asset Value(s)
4th Mar 20254:40 pmRNSTransaction in Own Shares
3rd Mar 20254:18 pmRNSNet Asset Value(s)
3rd Mar 202510:27 amRNSTotal Voting Rights
28th Feb 20253:09 pmRNSTerms of Appointment of New Investment Manager
27th Feb 20254:38 pmRNSTransaction in Own Shares
24th Feb 202512:23 pmRNSNet Asset Value(s)
24th Feb 202510:06 amRNSTransaction in Own Shares
14th Feb 20253:06 pmRNSNet Asset Value(s)
11th Feb 202510:25 amRNSTransaction in Own Shares
7th Feb 20254:50 pmRNSNet Asset Value(s)
3rd Feb 20255:53 pmRNSNet Asset Value(s)
3rd Feb 20259:09 amRNSTotal Voting Rights
24th Jan 20254:36 pmRNSNet Asset Value(s)
24th Jan 20253:02 pmRNSTransaction in Own Shares
20th Jan 202510:04 amRNSNet Asset Value(s)
14th Jan 202510:06 amRNSTransaction in Own Shares
10th Jan 20255:12 pmRNSNet Asset Value(s)
6th Jan 20251:49 pmRNSTransaction in Own Shares
2nd Jan 20255:10 pmRNSNet Asset Value(s)
2nd Jan 202511:41 amRNSTransaction in Own Shares
2nd Jan 202511:15 amRNSTotal Voting Rights
20th Dec 20245:12 pmRNSNet Asset Value(s)
20th Dec 20249:54 amRNSDirector Declaration
13th Dec 20243:41 pmRNSNet Asset Value(s)
12th Dec 20243:37 pmRNSDividend Declaration
11th Dec 202410:51 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.